ORBIMED ADVISORS LLC 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 6:45 pm Sale | 2024-09-30 | 13G | Elevation Oncology, Inc. ELEV | ORBIMED ADVISORS LLC | 2,441,275 4.000% | -558,725 (-18.62%) | Filing |
| 2024-02-14 6:42 pm Purchase | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | ORBIMED ADVISORS LLC | 3,000,000 6.800% | 3,000,000 (New Position) | Filing |